Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use PITAVASTATIN TABLETS safely and effectively. See full prescribing information for PITAVASTATIN TABLETS. PITAVASTATIN tablet, for oral use Initial U.S. Approval: 2009
Medication labelWhy this: Advisory · dailymed-prescription
Pitavastatin is indicated as an adjunctive therapy to diet in: Adult patients with primary hyperlipidemia or mixed dyslipidemia to reduce elevated total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (Apo B), triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C). Limitations of Use The effect of pitavastatin on cardiovascular morbidity and mortality has not been determined. Pediatric use information is approved for Kowa Co Ltd's LIVALO (pitavastatin) tablets. However, due to Kowa Co Ltd's marketing exclusivity rights, this drug product is not labeled with that information.
- generic_name
- pitavastatin calcium
- product_names
- pitavastatin calcium
- ndc
- 68180-735, 68180-736, 68180-737, 68180-735-09, 68180-735-02, 68180-736-09, 68180-736-02, 68180-737-09, 68180-737-02
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en